Kantarjian HM - Search Results

1

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Masarova L, et al. Among authors: kantarjian hm. Exp Hematol Oncol. 2017 Nov 9;6:30. doi: 10.1186/s40164-017-0090-5. eCollection 2017. Exp Hematol Oncol. 2017. PMID: 29152412 Free PMC article.

2

Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.

Cortes J, O'Brien S, Kantarjian H, Cork A, Stass S, Freireich EJ, Keating M, Pierce S, Estey E. Cortes J, et al. Leukemia. 1994 Dec;8(12):2174-8. Leukemia. 1994. PMID: 7808007

3

Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Cortes JE, Kantarjian H, O'Brien S, Keating M, Pierce S, Freireich EJ, Estey E. Cortes JE, et al. Leukemia. 1995 Jan;9(1):115-7. Leukemia. 1995. PMID: 7845005

4

All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia.

Cortes JE, Kantarjian H, O'Brien S, Robertson LE, Koller C, Hirsh-Ginsberg C, Stass S, Keating M, Estey E. Cortes JE, et al. Cancer. 1994 Jun 15;73(12):2946-52. doi: 10.1002/1097-0142(19940615)73:12<2946::aid-cncr2820731211>3.0.co;2-q. Cancer. 1994. PMID: 8199992 Clinical Trial.

5

Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.

Cortes J, Kantarjian H, O'Brien S, Robertson LE, Pierce S, Talpaz M. Cortes J, et al. Am J Med. 1996 Apr;100(4):452-5. doi: 10.1016/s0002-9343(97)89522-8. Am J Med. 1996. PMID: 8610733 Clinical Trial.

6

Chronic myelogenous leukemia: a review.

Cortes JE, Talpaz M, Kantarjian H. Cortes JE, et al. Am J Med. 1996 May;100(5):555-70. doi: 10.1016/s0002-9343(96)00061-7. Am J Med. 1996. PMID: 8644769 Review.

7

Acute lymphocytic leukemia: a comprehensive review with emphasis on biology and therapy.

Cortes JE, Kantarjian H, Freireich EJ. Cortes JE, et al. Cancer Treat Res. 1996;84:291-323. doi: 10.1007/978-1-4613-1261-1_13. Cancer Treat Res. 1996. PMID: 8724635 Review. No abstract available.

8

Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M. Sarris A, et al. Leuk Lymphoma. 1996 Mar;21(1-2):85-92. doi: 10.3109/10428199609067584. Leuk Lymphoma. 1996. PMID: 8907274

9

Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabine.

Cortes J, Kantarjian H, Talpaz M, O'Brien S, Beran M, Koller C, Keating M. Cortes J, et al. Leukemia. 1997 Jun;11(6):788-91. doi: 10.1038/sj.leu.2400677. Leukemia. 1997. PMID: 9177428 Clinical Trial.

10

A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Cortes J, Kantarjian H, O'Brien S, Beran M, Estey E, Keating M, Talpaz M. Cortes J, et al. Leukemia. 1997 Jul;11(7):929-32. doi: 10.1038/sj.leu.2400682. Leukemia. 1997. PMID: 9204970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,048 results

Search Page

Filters